Skip to main content
IMDX $3.46 +2.37%
IMDX logo
IMDX · Insight Molecular Diagnostics Inc.
Track IMDX — free
$3.46 +0.08 (+2.37%) At close · Oct 7
Market Cap
$113.23M
Shares
32.72M
Volume · Oct 7 153.87K Avg daily vol (3M) 236.92K
All webcasts

Earnings call · FY2022 Q2

Insight Molecular Diagnostics Inc. (IMDX) Q2 2022 Earnings Call

Concluded Aug 10, 2022
Aug 10, 2022 0 turns
Period
FY2022 Q2
Runtime
—
Sources
2 artifacts

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

3 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $237,000 -88.3% YoY
Diluted EPS -$1.48
Gross margin 13.1% +32.5 pp YoY
Net income -$8.30M

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Aug 10, 2022.

Metric Guided
Annual cash compensation costs decrease
annual
at least $4.5M
Employee severance and benefits charges Initiated
the third quarter of 2022
$2M
Annualized operating costs reduction
2023 as compared to 2022
$12M
Full-screen source Call document